ImaRX Therapeutics is a groundbreaking biopharmaceutical company, pioneering advanced micro bubble technology to target vascular disorders. Founded in 1999, the company focuses on developing innovative therapies for various vascular conditions, particularly stroke, by addressing vascular occlusions and the consequent ischemia. Its recent $7.00M Venture Round investment on 11 March 2005 reflects investor confidence in its cutting-edge approach. Specializing in Biotechnology and Health Care, ImaRX Therapeutics holds promise in transforming the landscape of vascular disorder treatments.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $7.00M | - | 11 Mar 2005 |
No recent news or press coverage available for ImaRX Therapeutics.